Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Author(s) -
Helen Jones,
Victoria S. Sprung,
Christopher J. A. Pugh,
Christina Daousi,
Andrew J. Irwin,
Nabil Aziz,
Valerie L. Adams,
E. Louise Thomas,
Jimmy D. Bell,
Graham J. Kemp,
Daniel J. Cuthbertson
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1382
Subject(s) - insulin resistance , polycystic ovary , medicine , nonalcoholic fatty liver disease , steatosis , hyperandrogenism , endocrinology , body mass index , fatty liver , obesity , adipose tissue , disease
Nonalcoholic fatty liver disease may be evident in women with polycystic ovary syndrome (PCOS), both conditions being associated with obesity and insulin resistance. However, few studies have accounted for the high prevalence of obesity in PCOS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom